Liberate Medical

Liberate Medical is a healthcare technology company focused on developing innovative solutions to improve patient outcomes in critical care settings. The company's flagship product, the VentFree Respiratory Muscle Stimulator, is designed to reduce disuse atrophy of the abdominal wall muscles in mechanically ventilated patients. This device has received emergency use authorization in the USA, particularly for patients with COVID-19, and is CE marked for sale in the European Economic Area. By reducing the duration of mechanical ventilation and ICU stays, VentFree aims to decrease morbidity, mortality, and post-discharge complications, ultimately leading to significant cost savings for healthcare providers. The business primarily serves hospitals and intensive care units, operating within the critical care medical device market. Liberate Medical generates revenue through the sale of its VentFree device and related services.

Keywords: respiratory muscle stimulator, mechanical ventilation, ICU, critical care, COVID-19, abdominal muscle atrophy, healthcare technology, emergency use authorization, patient outcomes, cost savings.